Dosimetric Comparison of Cesium-131 and Palladium-103 for Permanent Prostate Brachytherapy

Cancer types prostate


J.S. Musmacher, R.T. Byrnes, M. Ghaly, K. Satchwill, L. Rumpf

International Journal of Radiation Oncology Biology Physics
November 1, 2007
Mr. Musmacher and his physician colleagues (Smithtown, NY) report that Cesium-131 delivers a more homogenous dosimetric profile than Palladium-103 while maintaining essentially equivalent gland coverage. * Compared to other isotopes commonly used in permanent seed brachytherapy for prostate cancer

Related posts

Scroll to top